<DOC>
	<DOCNO>NCT01698658</DOCNO>
	<brief_summary>This clinical trial study ultrasound tomography use SoftVue diagnose woman breast cancer . New diagnostic procedure , ultrasound tomography use SoftVue , may help find diagnose breast cancer .</brief_summary>
	<brief_title>Ultrasound Tomography Using SoftVue Diagnosing Women With Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . Determine in-vivo image potential SoftVue 3-dimensional ( 3-D ) breast imaging . II . Acquire data SoftVue evaluation cohort 100 woman receive standard ultrasound ( US ) evaluation follow-up mammographic palpable abnormality construct reflection , sound speed attenuation image SoftVue . III . Evaluate ability SoftVue detect dominant breast finding ( i.e . major normal landmark architecture ) mass previously identify standard diagnostic evaluation ( palpation , mammography , standard US ) use standard clock position radial distance measurement nipple . IV . Conduct tomographic ( i.e . slice-by-slice ) comparison SoftVue magnetic resonance imaging ( MRI ) finding subgroup 50 patient . OUTLINE : Patients undergo ultrasound tomography use SoftVue . Some patient also undergo MRI breast .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Scheduled mammogram , breast ultrasound and/or breast MRI Breast size le 22 cm diameter ( ring diameter 22cm ) Able read understand provide inform consent Weight &lt; 350lbs ( patient bed max weight ) Nonpregnant nonlactating No open breast chest wound No active skin infection No serious medical psychiatric illness would prevent informed consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>